8 hours ago
By Kevin Kunzmann
The director of NIDA discusses the unprecedented impact of the pandemic on overdose deaths—and how substance use disorder care may still reach greater capability when all is said and done.
8 hours ago
By Kevin Kunzmann
Dementia and Alzheimer's disease cases are anticipated to boom in coming decades. One expert stressed the need for improved screening and facilitation of care at the earliest stages and signs.
9 hours ago
By Connor Iapoce
Data show the proportion of individuals with sustained clinical cure through Week 8 was 80.3% with CP101 treatment.
9 hours ago
By Kevin Kunzmann
The lead author of treatment recommendations weighs in on their current use and future research.
9 hours ago
By Kenny Walter
Initial studies have shown a 73% efficacy for FMT in treating patients with HVGD.
8 hours ago
By Kevin Kunzmann
The director of NIDA discusses the unprecedented impact of the pandemic on overdose deaths—and how substance use disorder care may still reach greater capability when all is said and done.
8 hours ago
By Kevin Kunzmann
Dementia and Alzheimer's disease cases are anticipated to boom in coming decades. One expert stressed the need for improved screening and facilitation of care at the earliest stages and signs.
9 hours ago
By Connor Iapoce
Data show the proportion of individuals with sustained clinical cure through Week 8 was 80.3% with CP101 treatment.
9 hours ago
By Kevin Kunzmann
The lead author of treatment recommendations weighs in on their current use and future research.
May 23, 2022 10:45 PM
By Connor Iapoce
May 23, 2022 9:00 PM
By Connor Iapoce
May 23, 2022 7:49 PM
By Kenny Walter
May 23, 2022 7:19 PM
By Alexandra Ward, MA
May 23, 2022 6:43 PM
By Kenny Walter
May 23, 2022 6:24 PM
By Giuliana Grossi
May 23, 2022 4:26 PM
By Giuliana Grossi
May 23, 2022 4:23 PM
By Kenny Walter
May 23, 2022 2:18 PM
By Kenny Walter
May 23, 2022 1:40 AM
By Connor Iapoce
May 23, 2022 12:15 AM
By Connor Iapoce
May 22, 2022 11:25 PM
By Kevin Kunzmann